What You Should Know: – Ellipsis Health and Ceras Health today announced a partnership that will integrate Ellipsis Health’s breakthrough technology that uses the human […]
Clinicians used to wonder if there was a role for mindfulness meditation in healthcare. But after the Covid-19 pandemic laid bare the overwhelming need for […]
Our attitudes to mental health are changing but much of the stigma that surrounds conditions such as schizophrenia remains – along with some enduring and […]
Medicine is pragmatic. It has often established that a treatment works well before it has understood how The chemical imbalance theory of depression is well […]
I guess there’s just no way to have a sacred cow without also keeping a goat. Understand, I’m not talking about a GOAT, as in […]
What You Should Know: – Wysa, a Boston, MA-based AI digital platform for mental health, today announces it has secured $20M in financing led by […]
Jorge E. Palacios, MD, Ph.D. – Senior Digital Health Scientist at SilverCloud Health It is no secret that one by-product of the ongoing pandemic is […]
What You Should Know: – Moving Analytics, an Irvine, CA-based telehealth provider of cardiovascular prevention programs raises $20M in Series A funding led by Wellington Access […]
Rachael Jones, SVP of Performance Analytics and Quality at Cotiviti In Florida, where Black residents are three times more likely to be hospitalized or die […]
Aniket Singh Rajput, Founder and CEO of Neuroglee Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in […]
What is the science behind the marketing of foods for antidepressant effects? If you go online, you can see claims about “coconut water being beneficial […]
Shares in Praxis Precision Medicines were in freefall today after the company’s efforts to develop a new therapy for major depressive disorder (MDD) ended in […]
This article is excerpted from the Hurdle Health Research Report “Voices of a Collective Experience: Vicarious Racism and its Effects on Black Mental Health.” In […]
What happened in states after medical marijuana laws were passed? Did opioid overdoses go up, stay the same, or go down? Millions of people in […]
Many students across the United States are socially and emotionally frozen at their age when the pandemic hit, according to school counselors surveyed by the […]
AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar in treatment-resistant depression, as it waits for a decision by […]
What You Should Know: – Digital care delivery company Amwell launches Amwell Comprehensive Behavioral Health Program, an evidence-based, comprehensive and scalable behavioral health solution that […]
Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies for patient monitoring, thanks to a new partnership with Empatica. […]
What You Should Know: – Osmind, a mental health EHR platform helping clinicians and researchers advance new life-saving mental health treatments, today announced a $40 […]
Geoffrey Boyce, CEO of Array Behavioral Care May is Mental Health Awareness Month, which for years has been a platform to increase understanding about mental illness and […]
The rate of tobacco use among American adults with major depression, substance use disorder or both was found to have decreased between 2006 and 2019, […]
Tom Zaubler, MD, Chief Medical Officer of NeuroFlow Since the passage of the Medicare Improvements for Patients & Providers Act in 2008, the U.S. healthcare […]
What You Should Know: – Can we build relationships with AI therapy bots as well as we can with other human beings? This research says […]
What You Should Know: – Today, Brightside Health announced it raised a $50M Series B, led by ACME Capital and Mousse Partners, bringing its total […]
Nate Treloar, COO & Co-Founder at Orbita Advances in conversational artificial intelligence are transforming basic chatbots into intelligent virtual assistants that provide comfort and utility […]
What You Should Know: – Today Grow Therapy, a leader in helping create life-changing therapeutic connections between therapists and clients, today announced that its mental health care services are now available as an […]
What did a randomized, placebo-controlled, double-blind study of a food that costs pennies a day for ragweed allergy sufferers find? A “great deal is asked […]
Mergers & Acquisitions (M&A) Activity OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform OptimizeRx, a provider of point-of-care technology solutions helping patients start and […]
Four years after spinning out from Belgium’s UCB, Syndesi Therapeutics and its SV2A modulator programme has been bought by AbbVie for $130 million upfront. The […]
What You Should Know: – This week, NeuroFlow announced a long-term deal with Aflac to provide the supplemental insurer’s employers with the technology platform. – […]
AbbVie has filed with the FDA to extend the uses of its bipolar disorder therapy Vraylar to include adjunctive therapy for major depressive disorder, part […]
Last year, the first phase 3 trial of Sage Therapeutics and Biogen’s antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability […]
Eleusis is developing a formulation of the psychedelic compound psilocybin that overcomes limitations of pill versions of the drug. Depression is Eleusis’s lead disease target […]
Centers for Medicare & Medicaid Services only recently gave the green light for Medicare Advantage (MA) plans to provide a wider range of benefits that […]
A prescription digital therapeutic (DTx) for leukaemia patients developed by Blue Note Therapeutics has been awarded breakthrough device status by the FDA. The DTx, called […]
What You Should Know: – Pear Therapeutics, Inc. (Nasdaq: PEAR), announced it has acquired two new digital therapeutic assets that it intends to integrate into […]
Compass Pathways has reported that its drug for treatment-resistant depression (TRD) based on magic mushroom ingredient psilocybin was effective in a phase 2b trial, although […]
The renaissance of Biogen and Sage Therapeutics antidepressant zuranolone continues, with the companies indicating they now plan to start a rolling submission for the drug […]
Odds are most women will get at least one false-positive mammogram, but, thankfully, most women who are called back for further testing of a suspicious […]
Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting […]
Researchers in the US have successfully treated a patient with severe depression via the use of an implant wired into the brain that interacts with […]
A study published by Verily researchers showed that some smartphone metrics, such as sentiment in weekly voice diaries, matched up with the severity of users’ […]
By HANS DUVEFELT Especially in these strange and uncertain times, many people feel uneasy. Some of them come to us with concerns over their state […]
The company recently finished a study showing patients in the U.K. who used both Sleepio’s app and therapy saw improvements in anxiety and depression compared […]
“Lead poisoning still occurs in the United States despite extensive prevention efforts and strict regulations.” Ayurvedic supplements specifically marketed to pregnant women, for example, exceeded […]
Depression is a common and serious medical condition that affects the way people behave, act and think in a negative manner. Also known as Major […]
The FDA was supposed to be delivering its verdict on Axsome Therapeutics’ depression therapy AXS-05 in less than a fortnight – but instead has delivered […]
By Nolan Brown, Marketing Intern, Butler University VMS BioMarketing Psoriasis is a chronic inflammatory disease of the skin that affects both the personal and social […]
Happify is making its app-based treatment available to patients thanks to a loosened FDA guidance last year that lets digital health companies targeting some behavioral […]
Happify Health has launched a prescription digital therapeutic (DTx) – called Ensemble – that can assist the treatment of people with both major depressive disorder […]
Investments in digital health firms are running high at the moment, and a $90 million round for four-year-old Woebot and its artificial intelligence-powered platform for […]
Testosterone is an essential hormone and steroid that affects many physiological functions. It is naturally more prevalent as an androgynous hormone in men, and it […]
Sage Therapeutics and Biogen’s antidepressant candidate zuranolone has hit its objectives in a phase 3 trial, but a falloff in efficacy over time has raised […]
A Sage Therapeutics depression drug that failed a pivotal study in 2019 has positive preliminary results from a new Phase 3 clinical trial, but the […]
Turns out a healthy body is tough to achieve without a healthy mind.
Researchers in the UK have found that there was a four million rise in prescriptions for antidepressants in England during 2020, adding £139 million to […]
By HANS DUVEFELT Primary Care is now mandated to screen for depression, among a growing host of other conditions. That makes intuitive sense to a […]
UK-based Small Pharma has launched on the Toronto’s TSX Venture Exchange, raising 63 million Canadian dollars (around £37m) to develop medicines based on dimethyltriptylene (DMT) […]
Healthcare staff are working through immense loss, grief and uncertainty to provide care during the Covid-19 pandemic. As organizations think about how to support their […]
The active compound in magic mushrooms – psilocybin – seems to be at least as effective as a commercially-available antidepressant in a phase 2 trial, […]
It may seem intuitive to avoid telehealth or remote care to avoid increased liability and malpractice exposure. But remote behavioral health assessment tools, real-time data-driven […]
Bent Philipson, Founder of Philosophy Care When it comes to skilled nursing facilities (SNFs) in particular and long-term care in general, a human-centered and empathetic […]
Otsuka Pharmaceutical is partnering with Click Therapeutics to launch a remote clinical trial to evaluate the effectiveness of digital therapeutics in reducing depressive symptoms.
Pharmaceutical wholesaler Lexon (UK) has lost its appeal against a £1.2 million fine in a case that accused it of exchanging commercially sensitive information about […]
Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully remote clinical trial testing a digital therapy […]
What You Should Know: – 98point6 announces the launch of its new virtual behavioral health service – 98point6 Primary Care Plus Behavioral Health. – With […]
Irv Lichtenwald, President & CEO of Medsphere Systems Corporation We’re now in a new year and new presidential administration. At least three companies are producing […]
What You Should Know: – Patients in the Cedars-Sinai COVID-19 Recovery Program receive a comprehensive in-person evaluation with an expert in infectious diseases or pulmonary […]
What You Should Know: – Washington, D.C.-based Hurdle raises $5M in seed funding to accelerate its digital mental health platform for people of color. – […]
The Pennsylvania-based insurer is offering members using its small group products access to the NeuroFlow app, which provides self-guided activities to combat mental health issues.
What You Should Know: – NeuroFlow raises $20M to expand its technology-enabled behavioral health integration platform, led by Magellan Health. – NeuroFlow’s suite of HIPAA-compliant, […]
John Frownfelter, MD, FACP, Chief Medical Information Officer at Jvion A century ago, X-rays transformed medicine forever. For the first time, doctors could see inside […]
Characterized by debilitating episodes of depression and mood elevation (mania or hypomania), Bipolar depression is an under-recognized and unappreciated phase of bipolar disorder. Since most […]
Novartis is to buy neuroscience drugs firm Cadent Therapeutics in a deal worth up to $770 million. The big Swiss pharma already has a presence […]
In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital […]
What You Should Know: – The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. […]
Increase in women being diagnosed with depression partly behind rise in use An increase in women being diagnosed with depression is partly behind a significant […]
With the prospects for its Alzheimer’s drug aducanumab still up in the air, Biogen has moved to shore up its late-stage pipeline with a $3 […]
Jenifer Leaf Jaeger, MD, MPH, Senior Medical Director, HealthEC Senior isolation is a health risk that affects at least a quarter of seniors over 65. […]
The Covid mental health crisis curve stands to cataclysmically increase the number of deaths associated with the pandemic.
What You Should Know: – The Veterans Health Administration has selected Ontrak in collaboration with Harvard Medical School and Brown University to transform suicide prevention […]
Alphabet’s “moonshot” subsidiary X shared that it failed to find a single biomarker for depression and anxiety. But the company still plans to make its […]
What You Should Know: – Ontrak acquires LifeDojo Inc, a San Francisco, CA-based comprehensive, science-backed behavior change platform. – The acquisition broadens Ontrak’s addressable market […]
Michael A Greely, Co-Founder & General Partner at Flare Capital Partners This will be ugly and sad. Racism has cost this country $16 trillion over […]
What’s the latest on treating depression with the spice saffron? Years ago, I covered a head-to-head comparison of saffron versus Prozac for the treatment of […]
Dr. Jacob Lazarovic M.D., IMCS Group As you read this, over 200,000 American deaths have been attributed to the virus. The influx of cases continues, […]
What You Should Know: – Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning […]
When food production technology made it possible, wheat flour processors started to eliminate the tough exterior (bran) and nutrient-rich core (germ) of the kernel to […]
What You Should Know: – Anthem extends the use of doc.ai’s platform and portfolio of privacy-first technologies and artificial intelligence software services to drive the […]
What You Should Know: – Mental health benefits provider Lyra Health raises $110M in Series D funding, bringing its valuation to $1.1 billion. – Lyra […]
What You Should Know: – Sonde Health acquires NeuroLex Laboratories, Inc. to forms one of the world’s preeminent biobanks focused on vocal biomarkers. – NeuroLex’s […]
What You Should Know: – Trellus Health secures $5M in seed funding and collaborates with Mount Sinai to deliver resilience-driven, connected care, integrating expert clinical […]
A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have […]
What You Should Know: – Ginger announces $50 Million in Series D funding to expand access to its on-demand mental healthcare system led by Advance […]
What You Should Know: – Innovaccer has recently partnered with CareSignal to address healthcare’s urgent need amidst the COVID-19 pandemic: to create and maintain solid, […]
– Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services […]
What You Should Know: – A new Accenture report called “Breakthrough Behavioral Health Access: Think Virtual” finds that the use of virtual behavioral health could […]
Eating seaweed salad may boost the efficacy of vaccinations and help treat cold sores, herpes, Epstein-Barr virus, and shingles. Billions of pounds of seaweed are […]
The post Bored? Then pay attention to this research appeared first on Healthy Debate.
There are all manner of purported hiccup “cures,” which include everything from chewing on a lemon, inhaling pepper, or, our dog’s favorite, eating a spoonful […]
Copyright © 2024 | WordPress Theme by MH Themes
